MG
IART icon

Michael Gelband’s Integra LifeSciences IART Stock Holding History

Michael Gelband’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-242,399
Closed -$2.28M – 1789
2026
Q1 		$2.28M Buy
242,399
+140,953
+139% +$1.55M 0.02% 740
2025
Q4 		$1.26M Buy
+101,446
New +$1.35M 0.01% 908
2025
Q1 		– Sell
-48,332
Closed -$1.1M – 1708
2024
Q4 		$1.1M Buy
+48,332
New +$1.05M 0.01% 921
2024
Q3 		– Sell
-24,775
Closed -$722K – 1815
2024
Q2 		$722K Buy
+24,775
New +$735K ﹤0.01% 1119
2023
Q4 		– Sell
-69,989
Closed -$2.67M – 1727
2023
Q3 		$2.67M Sell
69,989
-13,902
-17% -$585K 0.03% 584
2023
Q2 		$3.45M Buy
83,891
+53,049
+172% +$2.55M 0.03% 586
2023
Q1 		$1.77M Buy
+30,842
New +$1.74M 0.01% 930
2022
Q3 		– Sell
-56,823
Closed -$3.07M – 2073
2022
Q2 		$3.07M Buy
56,823
+28,447
+100% +$1.71M 0.04% 600
2022
Q1 		$1.82M Buy
28,376
+19,684
+226% +$1.3M 0.02% 827
2021
Q4 		$582K Buy
+8,692
New +$588K 0.01% 1321
2021
Q3 		– Sell
-8,513
Closed -$581K – 2349
2021
Q2 		$581K Buy
+8,513
New +$602K 0.01% 1285
2020
Q3 		– Sell
-6,892
Closed -$324K – 1964
2020
Q2 		$324K Buy
+6,892
New +$339K 0.01% 1281
2019
Q4 		– Sell
-3,968
Closed -$238K – 1690
2019
Q3 		$238K Buy
+3,968
New +$236K 0.01% 1027
2019
Q2 		– Sell
-10,767
Closed -$600K – 1209
2019
Q1 		$600K Buy
+10,767
New +$548K 0.04% 281

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Michael Gelband's IART Position: Q2 2026 in Review

Michael Gelband sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 242,399 shares — an estimated $2.28M sold.

Michael Gelband first reported a position in IART in Q1 2019 and held it in 14 quarters. The position peaked at $3.45M in Q2 2023. 211 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Michael Gelband reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 242,399 Integra LifeSciences shares in Q2 2026, an estimated $2.28M.
  • Michael Gelband first reported a position in Integra LifeSciences in Q1 2019 and held it in 14 quarters.
  • Michael Gelband's Integra LifeSciences position peaked at $3.45M in Q2 2023.
  • 211 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.